{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:58:40Z","timestamp":1794693520196,"version":"4.9.1"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamaoncol.2021.0687","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T18:51:48Z","timestamp":1619117508000},"page":"845","source":"Crossref","is-referenced-by-count":103,"title":["Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases"],"prefix":"10.1001","volume":"7","author":[{"given":"Steve","family":"Chmura","sequence":"first","affiliation":[{"name":"University of Chicago Comprehensive Cancer Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Winter","sequence":"additional","affiliation":[{"name":"NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Pisansky","sequence":"additional","affiliation":[{"name":"Department of Medicine-Medical Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Borges","sequence":"additional","affiliation":[{"name":"University of Colorado-Anschutz Medical Center, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hania","family":"Al-Hallaq","sequence":"additional","affiliation":[{"name":"University of Chicago Comprehensive Cancer Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Matuszak","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Medicine-Medical Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Arizona Medical Center \u2013 University Campus, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Hasan","sequence":"additional","affiliation":[{"name":"University of Chicago Comprehensive Cancer Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Bazan","sequence":"additional","affiliation":[{"name":"Ohio State University Comprehensive Cancer Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de L\u2019Universite de Montr\u00e9al, Hotel Dieu de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold A.","family":"Yoon","sequence":"additional","affiliation":[{"name":"Heartland Cancer Research National Cancer Institute Community Oncology Research Program, Decatur, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Horton","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Gan","sequence":"additional","affiliation":[{"name":"New Mexico Minority Underserved National Cancer Institute Community Oncology Research Program, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Milano","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin Ruth","family":"Sigurdson","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moughan","sequence":"additional","affiliation":[{"name":"NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Salama","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"White","sequence":"additional","affiliation":[{"name":"Ohio State University Comprehensive Cancer Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"coi210007r1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer.","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"coi210007r2","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.","volume":"372","author":"Postow","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"coi210007r3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.","volume":"113","author":"Pastorino","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"coi210007r4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1200\/JCO.1997.15.3.938","article-title":"Liver resection for colorectal metastases.","volume":"15","author":"Fong","year":"1997","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi210007r5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases.","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"7","key":"coi210007r6","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/cncr.28515","article-title":"Stereotactic body radiotherapy: a critical review for nonradiation oncologists.","volume":"120","author":"Kirkpatrick","year":"2014","journal-title":"Cancer"},{"issue":"26","key":"coi210007r7","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1200\/JCO.2014.55.9567","article-title":"Radical irradiation of extracranial oligometastases.","volume":"32","author":"Salama","year":"2014","journal-title":"J Clin Oncol"},{"issue":"10","key":"coi210007r8","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases.","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"coi210007r9","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases.","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"issue":"20","key":"coi210007r10","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1002\/cncr.27530","article-title":"Phase 1\/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases.","volume":"118","author":"Garg","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"coi210007r11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.prro.2012.08.006","article-title":"Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.","volume":"3","author":"Corbin","year":"2013","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"coi210007r12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/COC.0000000000000169","article-title":"Definitive stereotactic body radiotherapy (SBRT) for extracranial oligometastases: an international survey of >1000 radiation oncologists.","volume":"40","author":"Lewis","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"14","key":"coi210007r13","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/cncr.30058","article-title":"Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).","volume":"122","author":"Wong","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"coi210007r14","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/j.prro.2016.05.004","article-title":"Rationale of technical requirements for NRG-BR001: the first NCI-sponsored trial of SBRT for the treatment of multiple metastases.","volume":"6","author":"Al-Hallaq","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"coi210007r15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijrobp.2016.09.030","article-title":"Benchmark credentialing results for NRG-BR001: the first National Cancer Institute-sponsored trial of stereotactic body radiation therapy for multiple metastases.","volume":"97","author":"Al-Hallaq","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"coi210007r16","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small cell lung cancer: NRG Oncology\/RTOG 0813 trial.","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"issue":"12","key":"coi210007r17","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"coi210007r18","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small cell lung cancer: a phase 2 randomized clinical trial.","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"5","key":"coi210007r19","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ijrobp.2014.08.008","article-title":"Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.","volume":"90","author":"Modh","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"coi210007r20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial.","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10185","key":"coi210007r21","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomized, phase II, open-label trial.","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"coi210007r22","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/JTO.0b013e318219aac5","article-title":"Radiological changes after stereotactic radiotherapy for stage I lung cancer.","volume":"6","author":"Dahele","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"2","key":"coi210007r23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ijrobp.2010.12.002","article-title":"Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).","volume":"82","author":"Stephans","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"coi210007r24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195149","article-title":"Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: a multi-institutional pooled analysis.","volume":"13","author":"Hong","year":"2018","journal-title":"PLoS One"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2778658\/jamaoncology_chmura_2021_oi_210007_1623352011.07963.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T11:01:44Z","timestamp":1623927704000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2778658"}},"subtitle":["Findings From the NRG-BR001 Phase 1 Trial"],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.0687","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}